Trial Profile
Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Memantine (Primary) ; Riluzole (Primary)
- Indications Memory disorders; Mood disorders
- Focus Therapeutic Use
- 02 May 2013 New trial record